From AIDS Wards to Dispensaries: The LGBTQ Activists Who Built Medical Cannabis

With Pride Month approaching and the DEA’s first formal rescheduling order on the books, the legal cannabis industry is preparing to celebrate a milestone whose architects it has spent three decades quietly forgetting. The people who built America’s first dispensary were watching their partners die.

In 1990, San Francisco police raided the home of Dennis Peron and his partner Jonathan West, seizing four ounces of cannabis. West, dying of AIDS, weighed about 90 pounds and was covered in Kaposi sarcoma lesions; the plant was the only thing keeping food down. He testified that it was his, the charges were dismissed, and he died two weeks later. Peron has said the raid was the moment cannabis stopped being a libertarian cause and became a survival cause.

The medical cannabis industry usually credits one figure for that 1996 ballot measure: Peron. The Castro version is a multi-city LGBTQ activist history, messier and more honest. By 1994, nearly 20,000 San Franciscans, almost all gay men, had died of AIDS, and one Castro church was holding up to four funerals a day. The political vacuum that produced ACT UP produced the buyers club movement.

Where the Pride Month Story Stands, May 2026

The DEA’s April 23, 2026 final order placing certain marijuana products in Schedule III is narrow, covering only FDA-approved cannabis products and state-licensed medical marijuana. Federal cannabis remains illegal for most purposes under the same statute that forced the LGBTQ buyers club movement underground.

Sanchez Street and the First Medical Cannabis Dispensary

Peron, a Vietnam veteran who had sold cannabis in the Castro since the 1970s, began operating the San Francisco Cannabis Buyers Club out of his Sanchez Street apartment in October 1991. It was the first public medical cannabis dispensary in the United States. Membership exceeded 8,000 and required a doctor’s note confirming AIDS, cancer, or another qualifying condition. The club functioned more like a community center for the dying than a dispensary in the modern sense.

That November, San Francisco voters passed Proposition P with roughly 80 percent of the vote. Prop P had no force of law; it was a resolution urging police and prosecutors to deprioritize medical cannabis cases. The supermajority in the city most visibly bearing the AIDS death toll became the political collateral for the fight that followed.

Brownie Mary, Ward 86, and Care Work as Movement Infrastructure

Mary Jane Rathbun, known as Brownie Mary, was a retired waitress in her sixties when she began baking cannabis brownies for AIDS patients at San Francisco General Hospital’s Ward 86, the first inpatient AIDS unit in the country. She volunteered weekly from 1984 and, at her peak, baked roughly 600 brownies a day. Ward 86 named her Volunteer of the Year in 1986. Her first arrest, in January 1981, came after an undercover officer bought brownies and a search turned up 18 pounds of cannabis and 54 dozen brownies. She pled guilty and served her community service hours at the Shanti Project AIDS support nonprofit.

She was arrested three times. Reporters kept calling her a grandmother because that was the easier frame. She was performing volunteer hospice work in an epidemic the federal government had abandoned, and the wasting syndrome of late-stage AIDS responded to almost nothing else available. The buyers club she co-founded in 1991 with Peron and Dale Gieringer of California NORML inherited her model: the plant distributed inside a package of support, community, and dignity.

Philadelphia, ACT UP, and the Federal Door That Slammed Shut

The push was not only in San Francisco. In Philadelphia, Kiyoshi Kuromiya, a Japanese-American civil rights organizer born in a World War II internment camp and a founder of the Gay Liberation Front, started the Philadelphia chapter of ACT UP.^[5] After his 1989 AIDS diagnosis, he ran a buyers club distributing free cannabis to people with AIDS. In 1999 he was lead plaintiff in Kuromiya v. United States, arguing federal prohibition on medical cannabis for people with AIDS was unconstitutional. The case lost, but it put the government on the record about a program it had already quietly killed.

That program was the federal Compassionate Investigational New Drug initiative. Created in 1978 after glaucoma patient Robert Randall won the first successful medical necessity defense in U.S. case law, it supplied federally grown cannabis to a small group of patients. When AIDS hit, applications surged. Assistant Secretary for Health James O. Mason closed the program to new applicants on March 4, 1992, telling reporters that supplying cannabis to AIDS patients would create a “perception that this stuff can’t be so bad.” Two surviving patients still receive federal joints from the University of Mississippi. The government has been running a functional medical cannabis program for nearly fifty years while maintaining that the plant has no accepted medical use.

The Clinical Evidence Behind LGBTQ Medical Cannabis Activism

HIV-Associated Peripheral Neuropathy

Peer-reviewed research has since vindicated specific activist claims. The strongest evidence concerns HIV-associated peripheral neuropathy, a painful nerve condition affecting up to a third of people with HIV. A randomized placebo-controlled trial led by Donald Abrams and the UCSF medical cannabis research team, published in Neurology in 2007, randomized 55 patients to smoked cannabis at 3.56 percent THC three times daily for five days, or placebo cigarettes. Smoked cannabis cut pain by 34 percent against 17 percent on placebo; 52 percent of treated patients reported greater than 30 percent pain reduction, against 24 percent on placebo. An independent trial replicated the result.

The Safety Question

The federal safety argument for withholding the plant was addressed in a separate 2003 Abrams medical cannabis safety trial in the Annals of Internal Medicine: a 25-day inpatient study (n=62) finding no harm to CD4 or CD8 T-cell counts or viral load in HIV patients on protease inhibitors. Evidence on wasting syndrome is more modest and rests largely on dronabinol; the FDA added the AIDS-wasting indication in 1992, the year the Public Health Service closed Compassionate IND. The activists were right that the plant helped patients eat, sleep, and tolerate the early antiretroviral cocktails. The science caught up to them.

Proposition 215 and the LGBTQ History the Industry Forgot

Proposition 215, the Compassionate Use Act, passed on November 5, 1996 with 55.6 percent of the vote. The campaign drew heavily on the LGBTQ infrastructure built during the AIDS years: San Francisco’s gay political clubs, the Shanti network, ACT UP affiliates, and the buyers club membership itself. Co-authors included Peron, Gieringer, and Valerie Corral, who had founded the Wo/Men’s Alliance for Medical Marijuana (WAMM) in Santa Cruz in 1993. A month before the election, then-Attorney General Dan Lungren raided the buyers club and arrested Peron; the raid backfired, and the club reopened after the vote. Clinton Werner’s 2001 medical cannabis AIDS history in the Journal of Cannabis Therapeutics documents the collision in detail.

As California’s market formalized through the 2000s and into the adult-use era after 2016, the buyers club model (free or sliding-scale distribution inside a community-care container) was squeezed out by commercial dispensaries. WAMM, a nonprofit growing plants for terminally ill members for free, shut down in 2018 because the new adult-use framework did not accommodate compassion-based donation; it reopened in 2020 as a for-profit, WAMM Phytotherapies. Peron died in 2018, Brownie Mary in 1999, Kuromiya in 2000.

The movement won the policy fight and lost the institutional one. The dispensaries on every other corner in Los Angeles, Denver, and Detroit exist because people with AIDS forced a state to permit them, and rarely appear in those founding myths. As the industry absorbs a rescheduling that took thirty years and one funeral generation, the names worth knowing are Peron and Rathbun, Kuromiya and Corral, Randall and Gieringer, and the patients of Ward 86.

Frequently Asked Questions

Who founded the first medical cannabis dispensary in the United States?

The San Francisco Cannabis Buyers Club, the first public medical cannabis dispensary in the United States, was founded in 1991 by Dennis Peron, Mary Jane Rathbun (Brownie Mary), and Dale Gieringer of California NORML. It opened on Sanchez Street in October 1991 and grew to more than 8,000 members, most of them people with AIDS.

What role did LGBTQ activists play in legalizing medical cannabis?

LGBTQ activists organized the patient population that needed cannabis for AIDS wasting, nausea, and pain at the moment the federal government was refusing to study or approve it. They built buyers clubs, ran civil disobedience campaigns, and drafted the ballot measures that became San Francisco Proposition P in 1991 and California Proposition 215 in 1996, the first state-level medical cannabis law in the country.

Does the clinical evidence support cannabis use for HIV symptoms?

A 2007 randomized placebo-controlled trial led by Donald Abrams at UCSF found that smoked cannabis reduced daily pain from HIV-associated peripheral neuropathy by 34 percent, compared with 17 percent on placebo. A separate 2003 Abrams trial published in the Annals of Internal Medicine found no harm to CD4 or CD8 T-cell counts or viral load in HIV patients using cannabis short term. Evidence on wasting syndrome is more modest and rests largely on the synthetic THC analog dronabinol.

Why is Proposition 215 considered an LGBTQ political achievement?

Proposition 215 was conceived by Dennis Peron in memory of his partner Jonathan West, who died of AIDS in 1990. Its co-authors and campaign organization drew heavily on San Francisco’s LGBTQ political infrastructure, the buyers club membership, and ACT UP affiliates. The measure passed on November 5, 1996 with 55.6 percent of the vote, becoming the first state medical cannabis law in the United States.